文章摘要

文章信息/Info

Title:: -

作者:: 谭真综述; 黄德嘉审校; 四川大学华西医院心内科，四川成都 610041

Author(s):: -

关键词:: 细胞因子; 移植; 心血管疾病

Keywords:: -

分类号:: R541

DOI:: -

文献标识码:: A

摘要:: 细胞移植治疗心血管疾病是近年来探索的一种崭新的具有潜力的治疗方法，随着这方面研究的增多与深入，细胞因子在细胞移植治疗中所起的作用日益受到关注。某些细胞因子可诱导体外培养的供体细胞向心肌细胞方向分化并调控其增殖；细胞因子在缺血损伤处作为趋化因子吸引或动员体内某些干细胞或祖细胞也有着重要的治疗作用；移植细胞通过分泌细胞因子（旁分泌）促进血管生成被认为是细胞移植治疗心血管疾病的重要机制之一；此外细胞因子还具有若干其他的作用。作者对近期关于细胞移植治疗心血管疾病的研究中发现的细胞因子的作用作一综述。

Abstract:: -

参考文献/References

［1］ NadalGinard B, Kajstura J, Leri A, et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure［J］. Circ Res,2003，92:139-150.

［2］张航向，李源，臧益民. 干细胞移植与心血管疾病［J］. 心脏杂志，2002，14（6）：524-529.

［3］ Orlic D, Hill JM, Arai AE, et al. Stem cells for myocardial regeneration［J］. Circ Res, 2002,91:1092-1102.

［4］ Behfar A, Zingman LV, Hodgson DM, et al. Stem cell differentiation requires a paracrine pathway in the heart［J］. FASEB J, 2002,16:1558-1566.

［5］ Ciulla MM, Lazzari L, Pacchiana R, et al. Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury［J］. Haematologica,2003,88:614-621.

［6］ Cameliet P. Mechanism of angiogenesis［J］. Nat Med, 2000,6:389-395.

［7］ Isner JM. Myocardial gene therapy［J］. Nature, 2002,415:234-239.

［8］ Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebocontrolled, doubleblind, doseescalating trial of myocardial vascular growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia［J］. Circulation， 2002,105:2012-2018.

［9］ Miyagawa S, Sawa Y, Taketani S, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty［J］. Circulation，2002,105:2556-2561.

［10］Sakakibara Y, Nishimura K, Tambara K, et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation［J］. J Thorac Cardiovasc Surg， 2002,124:50-56.

［11］Yang Y, Jiang YM, Jamal R, et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESCdifferentiated cells［J］. J Appl Physiol， 2002,93:1140-1151.

［12］Kawamoto A,Gwon H,Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia［J］. Circulation, 2001,103:634-638.

［13］Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines［J］. Circulation, 2001,104:1046-1052.

［14］Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia［J］. J Am Coll Cardiol, 2001,37:1726-1732.

［15］Kinnaird T, Stabile E, Burnett MS, et al. Marrowderived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms［J］. Circ Res, 2004,94:678-685.

［16］Trusolino L, Gavassa S, Angelini P, et al. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity［J］. FASEB J, 2000,14:1629-1640.

［17］Liu Y, Rajur K, Tolbert E, et al. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways［J］. Kidney Int, 2000,58:2028-2043.

［18］Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bonemarrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improve cardiac function［J］. Nat Med, 2001,7:430-436.

［19］吴凡，谢家斌，邱汉婴. 细胞因子治疗病毒性心肌炎的研究进展［J］. 心脏杂志，2004，16（2）：163-168.

我们的网站为什么显示成这样？

细胞因子在细胞移植治疗心血管疾病中的作用(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics